a global total solutions provider dentsply sirona is the world’s largest manufacturer of professional dental products and technologies, empowering dental professionals to provide better, safer and faster dental care. our products and solutions include leading positions and platforms across consumables, equipment, technology, and specialty products. dentsply sirona is one global team that brings out the best in our people, lives and breathes high performance and personal accountability, acts with uncompromising integrity, improves the practice of dentistry with an unrelenting commitment to our customers and demonstrates a passion for innovation that shapes the dental industry. as the dental solutions company™, dentsply sirona provides dental professionals a comprehensive end-to-end solutions offering. this offering includes some of the best-known and established brands in the industry. we develop, manufacture and market a complete line of dental and oral health products, including gener
Company profile
Ticker
XRAY
Exchange
Website
CEO
Donald Casey
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Envista • ZimVie • SmileDirectClub • Sonendo • Biolase • Remedent • Item 9 Labs • Costas • Bruush Oral Care • Capstone Dental Pubco ...
Former names
DENTSPLY INTERNATIONAL INC /DE/
SEC CIK
Corporate docs
Subsidiaries
1.Augma Bio Materials Ltd. • 2.Barracuda Partners, L.P. • 3.Byte AU Pty. Ltd. • 5.Byteme Aligners Limited • 6.Clear Blue Smiles, Inc. • 7.Datum Biotech Ltd. • 8.Datum Dental Ltd. • 9.DeguDent GmbH • 11.Dentsply (Tianjin) International Trading Co. Ltd. • 13.Dentsply BX Sarl ...
IRS number
391434669
XRAY stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
10 Apr 24
DEFA14A
Additional proxy soliciting materials
10 Apr 24
DEF 14A
Definitive proxy
10 Apr 24
8-K
Changes in Registrant's Certifying Accountant
7 Mar 24
10-K
2023 FY
Annual report
29 Feb 24
8-K
Departure of Directors or Certain Officers
29 Feb 24
8-K
Dentsply Sirona Reports Fourth Quarter and Full Year 2023 Results, Provides Full Year 2024 Outlook, Raises Dividend
29 Feb 24
8-K
Results of Operations and Financial Condition
9 Jan 24
8-K
Regulation FD Disclosure
9 Nov 23
10-Q
2023 Q3
Quarterly report
2 Nov 23
Transcripts
XRAY
Earnings call transcript
2023 Q4
29 Feb 24
XRAY
Earnings call transcript
2023 Q3
2 Nov 23
XRAY
Earnings call transcript
2023 Q2
3 Aug 23
XRAY
Earnings call transcript
2023 Q1
3 May 23
XRAY
Earnings call transcript
2022 Q4
28 Feb 23
XRAY
Earnings call transcript
2022 Q3
14 Nov 22
XRAY
Earnings call transcript
2022 Q1
10 May 22
XRAY
Earnings call transcript
2021 Q4
28 Feb 22
XRAY
Earnings call transcript
2021 Q3
4 Nov 21
XRAY
Earnings call transcript
2021 Q2
5 Aug 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 309.00 mm | 309.00 mm | 309.00 mm | 309.00 mm | 309.00 mm | 309.00 mm |
Cash burn (monthly) | (no burn) | 9.08 mm | 83.33 mm | 11.08 mm | (no burn) | (no burn) |
Cash used (since last report) | n/a | 60.61 mm | 556.06 mm | 73.96 mm | n/a | n/a |
Cash remaining | n/a | 248.39 mm | -247.06 mm | 235.04 mm | n/a | n/a |
Runway (months of cash) | n/a | 27.3 | -3.0 | 21.2 | n/a | n/a |
Institutional ownership, Q3 2023
96.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 460 |
Opened positions | 58 |
Closed positions | 44 |
Increased positions | 160 |
Reduced positions | 167 |
13F shares | Current |
---|---|
Total value | 6.81 tn |
Total shares | 199.88 mm |
Total puts | 35.30 k |
Total calls | 99.40 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 25.25 mm | $862.56 bn |
BLK Blackrock | 16.13 mm | $551.14 bn |
Artisan Partners Limited Partnership | 12.94 mm | $441.87 bn |
First Eagle Investment Management | 9.67 mm | $330.20 bn |
STT State Street | 9.11 mm | $312.52 bn |
Nuance Investments | 8.90 mm | $304.07 bn |
JHG Janus Henderson | 7.43 mm | $253.65 bn |
Wellington Management | 6.72 mm | $229.51 bn |
T. Rowe Price | 6.08 mm | $206.63 bn |
MS Morgan Stanley | 6.01 mm | $205.24 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Apr 24 | Eric Brandt | Common Stock | Grant | Acquire A | No | No | 0 | 72.546 | 0.00 | 53,372.146 |
12 Apr 24 | Eric Brandt | Phantom Stock (Directors' Deferred Compensation) DDC Common Stock | Grant | Acquire A | No | No | 31.45 | 7.811 | 245.66 | 1,543.402 |
12 Apr 24 | Simon D Campion | Common Stock | Grant | Acquire A | No | No | 0 | 1,088.763 | 0.00 | 291,462.953 |
12 Apr 24 | Simon D Campion | Phantom Stock (Supplemental Executive Retirement Plan) SERP Common Stock | Grant | Acquire A | No | No | 31.45 | 17.471 | 549.46 | 3,452.021 |
12 Apr 24 | Coleman Glenn | Common Stock | Grant | Acquire A | No | No | 0 | 302.443 | 0.00 | 88,751.457 |
12 Apr 24 | Coleman Glenn | Phantom Stock (Supplemental Executive Retirement Plan) SERP Common Stock | Grant | Acquire A | No | No | 31.45 | 9.455 | 297.37 | 1,868.205 |
12 Apr 24 | Deese Willie A | Common Stock | Grant | Acquire A | No | No | 0 | 26.426 | 0.00 | 35,098.936 |
12 Apr 24 | Frank Andreas G | Common Stock | Grant | Acquire A | No | No | 0 | 503.503 | 0.00 | 133,383.793 |
12 Apr 24 | Frank Andreas G | Phantom Stock (Supplemental Executive Retirement Plan) SERP Common Stock | Grant | Acquire A | No | No | 31.45 | 39.562 | 1.24 k | 7,816.83 |
News
A Glimpse Into The Expert Outlook On Dentsply Sirona Through 4 Analysts
18 Apr 24
Barrington Research Maintains Outperform on Dentsply Sirona, Maintains $41 Price Target
18 Apr 24
Barrington Research Reiterates Outperform on Dentsply Sirona, Maintains $41 Price Target
1 Mar 24
Demystifying Dentsply Sirona: Insights From 4 Analyst Reviews
29 Feb 24
Needham Reiterates Buy on Dentsply Sirona, Maintains $42 Price Target
29 Feb 24
Press releases
Dentsply Sirona to Host First Quarter Conference Call on May 2nd
9 Apr 24
Credo Technology Group Holding Ltd Announces Appointment of Industry Veteran Clyde Hosein to Board of Directors
2 Apr 24
GE Vernova and Solventum Set to Join S&P 500; Dentsply Sirona to Join S&P MidCap 400; Others to Join S&P SmallCap 600
27 Mar 24
Dentsply Sirona Announces Retirement of Eric K. Brandt from the Board of Directors
29 Feb 24
Dentsply Sirona Reports Fourth Quarter and Full Year 2023 Results, Provides Full Year 2024 Outlook, Raises Dividend
29 Feb 24